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Summary In the present study, we investigated the effect of inteferon-gamma (IFN-y) on cellular calcium ion
concentration [Ca2+]i and inositol 1,4,5-trisphosphate (Ins 1,4,5-P3) formation in the human renal carcinoma
cell line CaKi-I. We also examined the possible role of a Ca2'-dependent mechanism during IFN-y-induced
intercellular adhesion molecule 1 (ICAM-1) antigen expression. IFN-y caused a rapid concentration-dependent
rise in [Ca2+]i, which was partly inhibited by diltiazem, a calcium channel blocker, TMB-8, an inhibitor of
intracellular calcium redistribution, and in calcium-free medium. IFN-y caused a fourfold increase in Ins
1,4,5-P3 formation. The induction of ICAM-1 antigen expression was synergistically enhanced by 4-
bromocalcium ionophore A23187. Finally, the calcium antagonists diltiazem, TMB-8 and EGTA, as well as
two potent inhibitors of Ca2+-dependent kinases, calmidazolium (R24571) and W7, had no or only a minor
inhibitory effect on IFN-y induction. Our data suggest that IFN-y increases [Ca2+]i in CaKi-l cells by
stimulating influx of Ca2+ and release of Ca2+ from intracellular stores, probably via Ins 1,4,5-P3 formation.
IFN-y signal transduction in our model may not be limited to an increase in [Ca2+]i and Ins 1,4,5-P3, since
IFN-y-induced ICAM-1 antigen expression was abrogated to a minor degree by calcium antagonists and not
coupled to Ins 1,4,5-P3 formation.
IFN-y is an inflammatory cytokine that is capable of enhanc-
ing anti-tumour immune response by inducing the surface
expression of different antigens, including intercellular
adhesion molecule-I (ICAM-1) and HLA class II, on tumour
cells (Mortarini et al., 1960; Azuma et al., 1992). The signal
transduction pathways used by IFN-y to modulate antigen
expression have been examined previously, but are still not
well understood. However, a constant finding has been the
activation of the Ca2" phospholipid-dependent protein kinase
C (PKC) by IFN-y in both normal and neoplastic cells (Fan
et al., 1988; Griffiths et al., 1990; Renkonen et al., 1990;
Hansen et al., 1993). In the U937 macrophage cell line (Klein
et al., 1990) and in human endothelial cells (Renkonen et al.,
1990), IFN-y-induced PKC activation has been shown to be
accompanied by inositol 1,4,5-trisphosphate (Ins 1,4,5-P3)
formation. These studies suggest that IFN-y receptor activa-
tion results in the cleavage of phosphatidylinositol bisphos-
phate into diacylglycerol and Ins 1,4,5-P3 by phospholipase C
(Downes & Macphee, 1990). While diacylglycerol can
activate PKC, Ins 1,4,5-P3 can increase cellular calcium ion
concentration, [Ca2+1]i.
We have recently shown that IFN-y can activate PKC in
the human renal carcinoma cell line CaKi-1 (Hansen et al.,
1993). However, this activation was not related to IFN-7-
induced ICAM-1 antigen expression, indicating that alterna-
tive signalling pathways may be stimulated, including other
Ca2'-dependent kinases. To our knowledge, there are no
previous studies which have investigated the ability of IFN-y
to increase [Ca2+]i and Ins 1,4,5-P3 formation in human renal
carcinoma cells.
In the present study we examined the role of Ca2+ and Ins
1,4,5-P3 as secondary messengers during IFN-y signalling in
CaKi-1 cells. Furthermore, the possible role of a Ca2+
dependent mechanism during IFN-7-induced ICAM-1
antigen expression was evaluated, since this adhesion
molecule can augment anti-tumoral immunity.
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Materials and methods
Reagents
Human recombinant IFN- (1-5 x I07 units per mg of pro-
tein) designated IFN-y 4A was purchased from Amersham
International (Denmark). The calcium ionophore, 4-
bromocalcium ionophore A23187 (bromo-A23187), diltiazem,
EGTA (N,N,N',N'-tetraacetic acid), TMB-8 [3, 4, 5-
trimethoxybenzoic acid 8-(diethylamino)octyl ester], R24571
(calmidazolium), W7 (N-6-aminohexyl-5-chloro- l-naphthale-
nesulphonamide hydrochloride) and compound 48/80 (con-
densation products of N-methyl-p-methoxy-phenethylamine
with formaldehyde) were obtained from Sigma (St Louis,
MO, USA). IFN-y was stored at 2-4°C diluted to 104 or
105unitsml-' in McCoy's 5a medium containing 10% fetal
bovine serum (FBS) (Gibco, Paisley, UK). Bromo-A23187
and R24571 were dissolved in dimethylsulphoxide (DMSO)
and 1 mg ml-' stock solutions were stored at - 80°C. All
other drugs were dissolved in water and I mgml-1 stock
solutions were stored at -20°C. The final concentration of
DMSO did not exceed 0.3% and cultures containing appro-
priate quantities of diluents were run in parallel to control
for minor effects.
Cell cultures
The human renal carcinoma cell line CaKi-1 was kindly
provided by J. Fogh (Novo Nordisk, Gentofte, Denmark)
and was originally isolated and characterised by the late J.
Fogh (Memorial Sloan Kettering, Rye, NY, USA; Fogh &
Trempe, 1975). The cells were maintained in MCoy's Sa
medium (Gibco) supplemented with 10% fetal bovine serum
(FBS) (Gibco), 2 mM glutamine (Gibco) and 100 IU ml-'
penicillin/streptomycin (Gibco). Cultures were incubated at
37'C in a 95% air, 5% carbon dioxide humid incubator.
Intracellular Ca2" measurements
Confluent monolayers of CaKi-1 cells were detached with
3 mM EGTA in Hanks' balanced salt solution without Ca2+/
Mg2+/phenol red pH 7.4 (HBSS) (Gibco) for 20 min at 37C,
washed twice and allowed to settle for 2 h in McCoy's 5a
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medium. Cells from 2-3 flasks (1 x 107) were pooled in
McCoy's 5a medium plus 0.5% bovine serum albumin (BSA)
(Sigma) and loaded with 2liM of the fluorescent dye, fura-2/
AM (Molecular Probes, OR, USA). The rise in [Ca2+], was
measured as previously described for fibroblasts
(Bouchelouche et al., 1988). The time course of changes in
fluorescence was measured with a Hitachi F 4000 spectro-
fluorimeter using a single excitation and emission wavelength
of 340 and 510 nm respectively. Drugs were added as
indicated.
Radioligand assay measurement ofIns 1,4,5-P3
Cellular Ins 1,4,5-P3 was measured initially using a com-
petitive binding assay (Chaliss et al., 1988; Palmer et al.,
1989) (Amersham International, Denmark). Briefly, confluent
CaKi-l cells in 75 cm2 flasks (I07 cells) were incubated with
10 mM inositol in 4 ml of McCoy's for 1 h, washed with
McCoy's and subsequently incubated in 4 ml of McCoy's
with 10 mm inositol and 10 mM lithium chloride for 30 min
at 37°C. After rewashing, cells were stimulated with IFN-y in
4 ml of McCoy's at the indicated times and concentrations.
The reaction was stopped with 2 ml of ice-cold 15% trich-
loroacetic acid (TCA). The cells were then transferred to
cryotubes (Nunc, Roskilde, Denmark), frozen in liquid nit-
rogen and kept at - 80°C. After thawing, samples were
centrifuged at 1,000g for 15 min at 4°C. The supernatants
were decanted and the pellets resuspended in ice-cold 15%
TCA for 20 min. The pellet suspension was then mixed,
centrifuged at 1,000g for 15 min at 4°C and pooled with the
corresponding supernatants. The TCA supernatants were ext-
racted four times with 5 ml of anhydrous diethylether and
adjusted to pH 7.5 with sodium bicarbonate. Sample aliquots
(1001l) were mixed with equal amounts of D-myo-[3H]Ins
1,4,5-P3 and bovine adrenal Ins 1,4,5-P3 binding protein,
vortexed and incubated for 15 min on ice. The samples were
then centrifugated at 1,000g for 30 min at 4°C. The super-
natants were decanted and the pellets were resuspended in
scintillant. Radioactivity was then measured by liquid scintil-
lation counting and Ins 1,4,5-P3 determined by comparison
with a standard curve containing 0.19, 0.38, 0.76, 1.5, 3.1,
6.2, 12.5 and 25 pmol of Ins 1,4,5-P3. Results are expressed in
pmol of Ins 1,4,5-P3 per 104 cells.
Analysis ofinositolphosphates by column chromatography
To confirm the binding assay, Ins 1,4,5-P3 was measured by
fast protein liquid chromatography (FPLC) on a Pharmacia
Mono-Q anion-exchange column as described by Chew and
Brown (1986) and Bouchelouche et al. (1990). Briefly, for
each reaction condition 107 CaKi-1 cells in 75 cm2 flasks were
incubated with D-myo-[3H]inositol (5I.tCi ml-') for 12 h in an
atmosphere of 5% carbon dioxide at 37°C. Cells were then
incubated for 30 min with 10 mM cold inositol and 10 mM
lithium chloride in McCoy's at 37°C. After incubation cells
were washed three times with McCoy's, reincubated with
10 mM lithium chloride in McCoy's for 10 min and
stimulated with IFN-y in 4 ml of McCoy's. The reaction was
stopped with 2 ml of ice-cold 15% TCA. The cells were then
transferred to cryotubes and TCA supernatants were ext-
racted as described for the radioligand assay measurements
of Ins 1,4,5-P3 (see above). Sample aliquots (200pl) contain-
ing the water-soluble inositol phosphates were separated
using the Mono-Q anion-exchange column equilibrated with
an ammonium formate (M)/formic acid (0.1 M) gradient and
an FPLC (Pharmacia) system (Chew & Brown, 1986). Frac-
tions of 3 ml were collected and radioactivities measured by
liquid scintillation counting. Three major peaks of radio-
activity were eluted from the column. These peaks coeluted
with 3H-labelled inositol standards (Du Pont/Dupharma,
Denmark) of inositol 1-monophosphate (Ins I-P), inositol
1,4-bisphosphate (Ins 1,4-P2) and Ins 1,4,5-P3 (Chew &
Brown, 1986; Bouchelouche et al., 1990).
Cell viability
Cell viability was assayed by determining trypan blue ex-
clusion microscopically and scoring a field of approximately
100 cells (Schlager & Adams, 1983).
Totalprotein synthesis measurement
The effect of calcium antagonist and protein inhibitors on
total protein synthesis was analysed as described by Ritchie
et al. (1991). Briefly, CaKi-l cells were grown for 48 h in
24-well plates in McCoy's 5a medium containing 2 mM
glutamine, 100 IU ml-' penicillin/streptomycin and 10%
FBS. Labelling was achieved by incubating cells for 24 h with
20ti Ci ml-' [35S]methionine with or without test agents.
After labelling, the cells were placed on ice and washed twice
with ice-cold HBSS. They were lysed in 500ftl of lysis buffer
(50 mM Tris pH 8.5/0.5% Triton X-100/0.25% deoxycholate/
10 mM EDTA/1 mM phenylmethylsulphonyl fluoride) for
15 min on ice. Lysates were transferred to tubes and a second
aliquot of lysis buffer was added to the wells. Lysates were
pooled and cleared by a 10 min centrifugation at 4°C. Ali-
quots of 250 gil were withdrawn from the supernatants to
which 250 gl of 20% TCA was added. After a 20 min incuba-
tion on ice, the precipitates were transferred to glass
microfibre filter discs on a vacuum manifold and washed with
5% cold TCA. Filters were dried and radioactivity was
measured by liquid scintillation counting. The means of trip-
licate experiments are expressed as per cent protein synthesis
compared with control cells.
Flow cytometric analysis ofICAM-1 antigen
At confluent monolayer in 75 cm2 tissue flasks, CaKi-I cells
were obtained for subculture by addition of 0.15% trypsin
(Gibco) in calcium-free phosphate buffer (pH 7.2), blocked
by McCoy's Sa with 10% FBS and the detached cells were
centrifuged and resuspended in fresh medium. A volume of
1 ml of a I0O cells ml-' suspension was seeded in 25cm2
tissue flasks (Nunc). After 48 h of culture, cells were treated
with IFN-y, bromo-A23187, diltiazem, EGTA, TMB-8,
R24571 and W7 in the indicated combinations, concentra-
tions and time courses. After stimulation, cells were washed
twice with HBSS/1% BSA. After washing, cells were
detached by incubation in 2 ml of 1 mM EDTA in HBSS/l %
BSA for 30 min at 37°C. A 100;d aliquot of the cell suspen-
sion was transferred to 12 x 75 mm polystyrene tubes (Fal-
con, Becton Dickinson) and incubated for 30 min at 4°C in
the dark with fluorescein isothiocyanate (FITC)-conjugated
monoclonal anti-ICAM-1, clone 84H10 (Makgoba et al.,
1988) (Immunotech, Marseilles, France), diluted 10glI in
10pl HBSS. After staining, cells were washed twice with
HBSS/1% BSA by centrifigation at 300g for 5 min and
resuspended in 500pil of fixation buffer (HBSS with 1%
paraformaldehyde, pH 7.4). Analysis of fluorescence was per-
formed on a FACScan (Becton Dickinson, Mountain View,
CA, USA). The background number of fluorescent cells (no
relevant monoclonal antibody) was generally adjusted to less
than 1% and the relative mean fluorescence intensity of
positive cells (MFI) was measured. The irrelevant mouse
IgGI FITC-conjugated antibody X927 (Dako, Denmark) was
used as a negative control. All MFI values are presented in a
linear scale (Figure 5a-f).
Assay ofprotein kinase A activity
Recent data suggest that cAMP-elevating agents can induce
ICAM-1 antigen expression in human glioma cells (Bouillon
et al., 1992). In order to evaluate the significance of cAMP-
dependent protein kinase (PKA) inhibition by the two
modulators of Ca2'-binding proteins used in this study,
namely R24571 and W7, PKA activity was assayed upon
IFN-y stimulation. CaKi-1 cells were grown to a confluent
monolayer in 75 cm2 flask with McCoy's 5a medium supp-
lemented as described above. Following stimulation of the
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the medium and rinsing the monolayers twice in ice-cold
PBS. After rinsing, flasks were maintained at 4°C while cells
were gently scraped in 4 ml of ice-cold extraction buffer
(5 mM EDTA, 50 mM Tris, pH 7.5). The cells were
homogenised for 15 strokes on ice in a precooled Dounce
homogeniser and left on ice for 30 min. To remove cellular
debris the homogenate was centrifuged at 2,000g for 10 min.
The supernatants were removed and assayed for PKA
activity. PKA was measured by the incorporation of 32p from
100IJM [y-32P]ATP (1 X 105d.p.m. nmol ', Amersham) into
each sample in the presence or absence of cAMP (40 nM)
with or without the heat-stable rabbit skeletal muscle PKA
inhibitor protein PKI (6-22)NH2 (4gM in 50 mM Tris,
pH 7.5) using the PKA assay system (3128SA, Gibco,
Paisley, UK). Substrate phosphorylation in the presence of
cAMP reflected the total amount of PKA in each sample.
The background (substrate phosphorylation in the presence
of PKI) was subtracted from each sample, and PKA activity
was expressed as the percentage of activated PKA per total
PKA.
Statistics
All results represent the mean ± s.d. of three different
experiments. Data were analysed by Student's t-test. P<0.05
was considered statistically significant.
Results
Effect ofIFN-y on [Ca2+]i andpossible source ofcalcium
increase
To determine the effect of IFN-y on [Ca2+]i cells were
stimulated with 10, 50, 100 and 500 units ml-' IFN-y and the
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fura-2/AM-fluorescence was measured continuously with
time. Figure la shows the dose- and time-dependent change:
maximal levels were reached within 1 min of stimulation. In
order to examine the ability of IFN-y to increase [Ca2+]i by
increasing Ca2+ influx from the medium as well as by releas-
ing Ca2+ from intracellular stores, CaKi-1 cells were
incubated with decreasing levels of Ca2+ before IFN-'y
stimulation. Figure lb shows the effect of IFN-y
(500 units ml-') in medium containing 1 mM Ca2 , 0.32 mM
Ca2 , or free of Ca2+ (omission of calcium and addition of
0.40 mM EGTA). Reducing extracellular Ca2+ reduced the
IFN-y-induced rise in [Ca2+],. In the absence of extracellular
Ca2 , IFN-y was still able to induce a [Ca2 ]i response
(Figure lb; Medium: Ca2+ free), indicating Ca2+ release from
intracellular stores. For comparison [Ca2+], was measured
after stimulation with bromo-A23187, a non-fluorescent cal-
cium ionophore which increases [Ca2+]i by transporting cal-
cium ions across biological membranes (Luckasen et al.,
1974). Figure lc shows that bromo-A23187 also increased
[Ca2+]i by enhancing Ca2+ influx as well as by releasing
intracellular Ca2 , since there was a significant, but reduced
[Ca2+]i rise in medium free of Ca2+. The dependence of the
IFN-y-induced rise in [Ca2+], on both Ca2+ influx and int-
racellular Ca2+ release was further supported by pretreating
CaKi-l cells with diltiazem (1I1AM) or TMB-8 (75 JM) for
60min before IFN-y (500unitsml1') stimulation. Figure ld
shows the reduced rise in [Ca2+]i after blocking Ca2+ chan-
nels with diltiazem or intracellular Ca2+ redistribution with
TMB-8 (Malagodi & Chiou, 1974; Owen & Villereal,
1982).
Effect ofIFN-y in inositolphosphateformation
The observed [Ca2+], increase to IFN-y stimulation in Ca2+-
free medium and reduced response after TMB-8 pretreatment
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Figure 1 Spectrofluoriometric analysis of [Ca2]i (nM) in fura-2/AM-loaded CaKi-I cells, after IFN-y or bromo-A23187 stimula-
tion. a, Effect of IFN-y stimulation on [Ca2+]i as related to IFN-y dose (10, 50, 100 and 500 units ml-'). b, Effect of IFN-y (500
unitsml-'). c, Bromo-A23187 (0.51M) stimulation of [Ca2]i as related to Ca2+ in the medium. Ca2"-free medium is defined as
omission of calcium and addition of 0.40 mm EGTA. d, Effect of IFN-y (500 units ml-') on [Ca2+]i as related to Ca2+ antagonist
treatment. Cells were preincubated with TMB-8 (75jLM) or diltiazem (dilt.) (1 LuM) for 60 min before IFN-'y stimulation. Control
indicates non-pretreated cells. Representative traces of three experiments.
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indicates mobilisation of Ca'+ from intracellular stores.
Therefore, we examined the ability of IFN-y to increase
intracellular levels of Ins 1,4,5-P3 (Table I). Table I shows
that IFN-y caused a concentration-dependent rise in Ins
1,4,5-P3 after I min stimulation. IFN-y at 10 units ml-' was
enough for an almost maximal Ins 1,4,5-P3 production.
Figure 2 illustrates the time course for Ins 1,4,5-P3 formation
after stimulation with 500unitsml-' IFN-y. Maximal levels
were reached within 1 min. This corresponds with the time
for maximal [Ca2'], increase after stimulation with
500 units ml-' IFN-y (Figure la). In order to confirm the
radioligand assay experiments (Table I), inositol phosphate
formation was further analysed by FPLC (Table I1). As
shown in Table II. IFN-y stimulated a significant increase in
Ins 1-P and Ins 1,4,5-P3. There was a slight increase in Ins
1.4,-P,. but this did not reach significant levels. Figure 3
shows a typical elution pattern of water-soluble inositol
phosphates from Mono-Q columns. Thus, the FPLC analysis
supports the radioligand assay experiments.
Effeect of calcimw antagonists an1d proteinl inhlibitors o? ce/ll
viatilitYi at(l total pr-otein? sYnthesis
To further investigate the role of Ca-+ and Ca-+-dependent
proteins in CaKi-l cells during IFN-y stimulation, we tested
the effect of diltiazem, EGTA, TMB-8 and Ca'2 -binding
protein inhibitors on IFN-y-induced ICAM-1 antigen expres-
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sion. Since ICAM-1 induction may depend on de) noi'o pro-
tein synthesis, we assayed cell viability and total protein
synthesis by trypan blue exclusion and metabolic labelling
with [33S]methionine to examine non-specific confounding
effects of these drugs. Cell viability was unaffected by dil-
tiazem (1 tIM), EGTA (1 mM), TMB-8 (75 tIM), R24571
(10 ,lM) or W7 (40lIM) treatment for 24 h. However, the
calmodulin antagonist c48/80 (Gietzen, 1983) reduced cell
viability to 65-80% with signs of cell detachment at doses as
low as 5 )iM. In light of these results c48/80 was excluded
from the subsequent experiments. Figure 4 shows that, des-
pite normal viability, pretreatment of CaKi-l cells for 24 h
with R24571 (5- 10iM) or W7 (20-401,M) resulted in a
5-20% decreased protein synthesis. This was not the case for
a 24 h pretreatment with diltiazem (1 jiM), EGTA (1 mM) or
TMB-8 (75 tiM). Accordingly, protein synthesis was taken
into account for normalising ICAM-1 antigen expression
after R24571 and W7 inhibition (Ritchie et al., 1991).
Effect of IFN-y and hromno-A23187 oni ICAM-1 anitigeni
e.Yprees Ion
CaKi-l cells were incubated with 10, 100 or 500 units ml-'
IFN-y for 24 h. The data in Figure 5a show that IFN-y
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Figure 2 Time-depenident rise in Ins 1,4,5-P, as determined by
radioligand assaI)y in CaKi-l cells stimulated with 500 units ml-
IFN-y for 1 mnim. Values represent mean + I s.d. of three
experiments.
Table I Radioimmunoassay measurement of Ins 1,4.5-P3 in CaKi-I
cells after min stimulation with IFN-- (mean ± s.d. of three
experiments)
IFN-y (unit%s ml' Ins 1,4,5-P3 (P170o 10-' celis)
0 (control) 0.3 + 0.1
10 1.1+0.1 (P<0.02)
100 1.2+0.4 (P<<0.02)
500 1.6 +0.3 (P <0.02)
Table 11 FPLC analysis of inositol phosphate turnover in CaKi-I
cells after 1 min stimulation with IIFN-y (500 units ml-') (meian + s.d.
of three experiments)
Inositol phosphlate.s (radio-
actiiVitY c.p.mn. per fraction) C'onitrol IFN-y
Ins 1-P 193 10 467 7 (P<0.01)
Ins 1,4-P, 35 ± 6 84 + 35 (non-significant)
Ins 1,4,5-PA 35 + 12 129 9 (P <0.01)
Figure 3 Elution pattern of CaKi-I cell [3H]inositol phosphates
isolated with a Pharmacia Mono-Q column. Open circles indicate
basal values and closed circles indicate values from IFN-y
(500 units ml-' for min)-stimulated cultures. Representative
trace of three experiments.
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Figure 4 Effect of calcium antagonists and protein inhibitors on
total protein synthesis. CaKi-l cells were treated for 24 h with
diltiazem (dilt.), EGTA. TMB-8. R24571 or W7 in the indicated
concentrations. Protein synthesis was assessed by V3S]methionine
incorporation. Data represent mean ± I s.d. of three experiments.
*Significant differences from control value.
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Figure 5 FACS analysis of ICAM-1 antigen expression in CaKi-l cells. a, Cells were incubated with increasing doses of IFN-y for
24 h. b, Effect of 24 h incubation with bromo-A23187 (0.5ILM) and/or IFN-y (500 units ml-'). c, Effect of diltiazem (dilt.) (I [PM),
EGTA (1 mM) or d, TMB-8 (75pM) on IFN-y (500 units ml ')-induced ICAM-l antigen expression. Cells were pretreated with
inhibitors for 60 min before IFN-y incubation for 24 h. e, Effect of R24571 (10 tIM) or f, W7 (40 liM) on IFN-y (500 units ml-')
induction. Cells were pretreated with inhibitors for 60 min before IFN-y incubation for 24 h. ICAM-1 (MFI) was normalised
according to total protein synthesis for R24571 (R24571-Normalised) and W7 (W7-Normalised). Data represent mean ± 1 s.d. of
three experiments. *, '*Significantly (P<0.05) higher than control and IFN-y values respectively. `Significantly (P<0.05) lower
than IFN-y value.
caused an increase in ICAM-1 antigen expression above con-
trol value at 100 and 500 units ml'. IFN-y at 10 units ml-'
had no effect on ICAM-1 antigen expression, although this
dose yielded a clear [Ca2+]i rise (Figure la) and an almost
maximal Ins 1,4,5-P3 production (Table I). To investigate the
role of calcium during ICAM-1 antigen induction we
incubated cells with bromo-A23187 (0.5 tIM) for 24 h.
Bromo-A23187 significantly raised ICAM-1 antigen expres-
sion after 24 h (Figure 5b). Furthermore, combining full
doses of IFN-y (500 units ml-') and bromo-A23187 for 24 h
significantly increased ICAM-1 antigen expression as com-
pared with either agent alone (Figure Sb). This increment
showed a slight synergy with a mean MFI of 272, since the
sum of the two agents mean increment was 187 MFI.
Effects ofinhibition ofcalcium transients on IFN-y-induced
ICAM-I antigen expression
To determine the functional significance of extracellular cal-
cium, cells were pretreated for 60 min at 37°C with the
calcium channel blocker diltiazem (I jiM) or the Ca2+
chelator EGTA (I mM), before addition of IFN-y (500 units
ml-') for 24 h. Figure Sc shows that, in the presence of
diltiazem or EGTA, the mean MFI decreased from 531 ± S
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to 508 ± 7 and 493 ± 23 respectively. Despite statistical
significance, these differences represent a weak non-con-
clusive decline in ICAM-1 antigen expression. The two
antagonists had no effect on basal ICAM-1 antigen expres-
sion when used alone. To examine whether cellular calcium
stores contribute to an increase in ICAM-1 antigen expres-
sion, CaKi-l cells were pretreated with TMB-8 (75 tM) for
60 min at 37°C followed by addition of IFN-'y (500 units ml-')
for 24 h. TMB-8 significantly reduced IFN-y-induced ICAM-
1 antigen expression from 579 ± 1 (MFI) to 514 ± 1 (MFI).
This represents a partial reduction of only 11%. TMB-8 had
no effect on basal ICAM-1 antigen expression.
Effect ofR24571 and W7 on IFN-y-induced ICAM-1 antigen
expression
Since ICAM-1 antigen expression may be induced by a
[Ca2+]i rise via activation of Ca2"-binding proteins, CaKi-l
cells were pretreated with R24571, an anti-mycotic agent, and
W7, a naphthalenesulphonamide, both potent inhibitors of
Ca2'-binding proteins including PKC and calmodulin
(Gietzen et al., 1981; Tanaka et al., 1983). Incubation of cells
with R24571 (10 tiM) or W7 (40 !LM) for 60 min at 37°C
before addition of IFN-y (500 units ml-') for 24 h signi-
ficantly reduced IFN-7-induced ICAM-1 antigen expression
(Figure Se and f). However, when the total protein synthesis
was taken into account for normalising ICAM-1 antigen
expression, R24571 had no inhibitory effect, while W7 only
inhibited ICAM-1 antigen induction from 579 ± 1 (MFI) to
526 ± 22 (MFI), less than 10% (Figure 5e: IFN-y + R24571-
Normalised; and Figure Sf: IFN-'y + W7-Normalised). Since
the differences in ICAM-1 antigen expression obtained upon
IFN-y treatment with or without calcium antagonists or pro-
tein inhibitors were weak, we examined the FACS profile
(cell distribution) in addition to the MFI. Figure 6 illustrates
representative traces from the FACS analysis indicating a
highly homogeneous CaKi-I cell population with minimal
variation.
Effect ofIFN-y on PKA activity
The control level of PKA activity in CaKi-1 cells was
6.0 ± 1.7%. This level was unaffected by stimulation with
IFN-y (500 units ml-') for 15, 30 and 60 min, which yielded a
PKA activity between 5.6 ± 1.4% and 7.8 ± 1.5%. These
results support the hypothesis that the inhibitory effect of W7
on IFN-y-induced ICAM-1 antigen expression was not
caused by PKA inhibition. Hence, although cAMP-elevating
agents can enhance ICAM-1 antigen expression, possibly via
PKA (Bouillon et al., 1992), and although the potent cal-
modulin antagonist W7 may act upon PKA at 40liM
(Hidaka et al., 1984), this was unlikely to be the case in
CaKi-I cells.
Discussion
IFN-y has been used alone or in combination with IFN-c as
an immunotherapeutic agent in patients with renal cell car-
cinoma (Heicappell & Ackermann, 1990). One of the main
anti-tumoral effects of IFN-y is the induction of cell-surface
antigens, including ICAM-1, by activating different intracel-
lular signal transduction pathways (Azuma et al., 1992;
Bouillon et al., 1992; Hansen et al., 1993). In different cell
types IFN-y has been shown to activate PKC and/or increase
Ins 1,4,5-P3 formation, indicating stimulation of the phos-
phatidylinositol-Ca2+ signal transduction pathway (Klein et
al., 1990; Renkonen et al., 1990). We have recently demon-
strated PKC activation as well as ICAM-1 antigen induction
upon IFN-y treatment of CaKi-I cells (Hansen et al., 1993).
Therefore, for the first time, we decided to examine the role
ofCa2+ and Ins 1,4,5-P3 formation during IFN-y stimulation
of this human renal carcinoma cell line, and relate these
findings to ICAM-1 antigen induction.
Our findings showed a dose-dependent ability of IFN-y to
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Figure 6 FACS profile from the analysis of ICAM-1 antigen
expression on CaKi-I cells. Cells were untreated (control) or
treated with IFN-y (500unitsml-') for 24h with or without a
60 min preincubation with TMB-8 (75pM) (top) or W7 (40 tM)
(bottom).
increase [Ca2+]i by inducing influx of Ca2+ and redistribution
of intracellular Ca2+ stores. An influx of extracellular calcium
after IFN-y stimulation was supported by the inhibition of
the rise in [Ca2 ]i by removal of extracellular Ca2+ (Figure
lb) and by blocking calcium channels with diltiazem (Figure
Id). Redistribution of intracellular calcium was supported by
the failure to completely block the increase in [Ca2+], with
Ca2'-free medium and by inhibition with TMB-8 (Figure
ld). Since TMB-8 is a known inhibitor of intracellular Ca2+
redistribution (Malagodi & Chiou, 1974; Owen & Villereal,
1982), and since Ins 1,4,5-P3 is a natural releaser of Ca2+
from intracellular stores (Downes & Macphee, 1990), IFN-y-
stimulated formation of Ins 1,4,5-P3 was examined. We
found a signficant increment in Ins 1,4,5-P3 using two
independent methods, a radioligand assay (Table I and
Figure 2) and FPLC (Table II and Figure 3), which suggests
that IFN-y-induced redistribution of intracellular calcium
may be mediated by this phosphatidylinositol metabolite.
Usually high-performance liquid chromatography (HPLC) is
used for separation of inositol phosphates (Burgess et al.,
1985; Turk et al., 1986; Klein et al., 1990). However, the
FPLC system appears to be superior in its ability to rapidly
separate inositol phosphates while maintaining good resolu-
tion (Florholmen et al., 1989).
Often, only cell viability by dye exclusion or 'signs of
toxicity' not otherwise specified are described when protein
inhibitors are used in the study of antigen expression in cell
cultures (Rothlein et al., 1988; Griffiths et al., 1990; Pedrinaci
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et al., 1990). However, this may be misleading, since total
protein synthesis can be inhibited despite normal cell
viability, as shown for R24571 and W7 in CaKi-1 cells
(Figure 4). The inhibition of total protein synthesis by these
two inhibitors is a non-specific effect in relation to ICAM-1
antigen expression. Normalising ICAM-1 antigen expression
to total protein synthesis revealed a markedly reduced effect,
with only W7 reaching significant inhibition (Figure 5e and
f). Similar findings have been obtained with the PKC
inhibitors H7 and staurosporine (Ritchie et al., 1991; Bouil-
lon & Audette, 1993). Unfortunately, compound 48/80 could
not be used because the cell viability was affected at even low
doses.
The enhancement of ICAM-1 antigen expression in CaKi-l
cells by IFN-y as assessed by FACS was approximately 1.3-
to 1.4-fold. Although this represents a weak response as
compared with other cell types, such as melanoma cells
(Scheibenbogen et al., 1993), the FACS profile showed a
highly homogeneous cell population (Figure 6). Furthermore,
our data clearly demonstrated that IFN-y-induced Ins 1,4,5-
P3 formation was not coupled to ICAM-1 antigen expression
because 10 units ml-' IFN-y was enough for an almost max-
imal Ins 1,4,5-P3 formation (Table I), whereas it had no effect
on ICAM-1 antigen expression (Figure 5a). Also, in the
presence of either diltiazem, EGTA or TMB-8, the IFN-y-
stimulated ICAM-l antigen expression decreased by less than
15% (Figure 5c and d). Therefore, although statistically
significant, such weak differences may not reflect a
biochemically relevant phenomenon. Hence, the lack ofcoup-
ling between Ins 1,4,5-P3 formation and ICAM-1 antigen
induction by IFN-y as well as the lack of inhibition of this
induction by calcium antagonists indicate that a
Ca2+-phophatidylinositol signalling mechanism does not
play a major role in IFN-y-induced ICAM-1 antigen expres-
sion in CaKi-l cells. This does not exclude the possibility
that raising [Ca2+]i by mechanisms other than those applied
by IFN-y can potentiate IFN-y induction. Thus, as illustrated
in Figure Sb, raising [Ca2+]i with bromo-A23187 synergis-
tically enhanced IFN-y-induced ICAM-1 antigen expression.
If IFN-y raised ICAM-1 antigen expression by increasing
[Ca2+]i, then its combined effect with bromo-A23187 may
have been predicted to be additive. The minor role of a
Ca2"-dependent mechanism during ICAM-1 antigen induc-
tion by IFN-y was further supported by the weak inhibition
of this induction by W7 (Figure 5f). The naphthalenesul-
phonamide derivative W7 is a potent calmodulin antagonist,
but may act upon several protein kinases at high concentra-
tions.(Tanaka et al., 1983: Hidaka et al.,1984). These include
the cAMP-dependent PKA and PKC, besides its actions via
calmodulin on calmodulin-dependent proteins. Since both
cAMP-elevating agents and PKC activators can enhance
ICAM-1 antigen expression (Griffiths et al., 1990; Bouillon et
al., 1992) the W7 effect could have been ascribed to PKA
and/or PKC inhibition, and not just calmodulin antagonism.
However, IFN-y did not stimulate PKA activity in CaKi-l
cells. Furthermore, although IFN-y activates PKC in CaKi-l
cells as assayed by both histone and acetylated myelin basic
protein peptide (4-14) substrate phosphorylation, inhibition
of PKC with H7 and sphingosine had no effect on IFN-y-
induced ICAM-1 antigen expression (Hansen et al., 1993). In
light of these findings, it is very unlikely that W7, a weaker
PKC inhibitor than H7 and sphingosine, abrogated that
IFN-y induction by affecting PKA or PKC. The exact cal-
modulin-dependent proteins affected by W7 in our model are
unknown, since calmodulin can activate a wide range of
kinases and cyclases, including CaM kinase II, phosphorylase
kinase, adenylate cyclase and guanylate cyclase (Brady et al.,
1985). As discussed above, the non-specific effect of W7 on
total protein synthesis was accounted for by normalising
ICAM-l antigen expression.
Our results partly agree with earlier studies on IFN-y
signalling in other cell types. In human endothelial cells,
IFN-y activates PKC and induces Ins 1,4,5-P3 (Renkonen et
al., 1990). Using similar radioligand assay conditions for Ins
1,4,5-P3 quantitation as in our study, Renkonen et al. (1990)
showed a maximal rise after 10 min of stimulation, with no
significant rise within 1 min. This discrepancy, as compared
with CaKi-1 cells, may relate to the malignant transforma-
tion itself or to the different embryonal origins of the cell
lines. However, Renkonen et al. (1990) did not confirm their
measurements of inositol trisphosphate formation with other
independent assays, but were able to show a significant 1.4-
fold increase in the efflux of 45Ca2" 5 min after IFN-y
stimulation. Furthermore, although W7 was shown to
decrease IFN-7-induced ICAM-1 antigen expression, this
decrease was less than 20% and also not normalised to total
protein synthesis. Therefore, the W7 effect may well have
been non-specific. Our data are consistent with the findings
of Klein et al. (1990), who demonstrated that IFN-y caused a
significant increase in Ins 1,4,5-P3 formation within 1 min in
U937 cells, using a identical radioligand assay and HPLC.
The IFN-y-induced rise in Ins 1,4,5-P3 was correlated to a
rise in [Ca2]i. In agreement with our study, W7 had little or
no effect on IFN-y-induced antigen expression in U937 cells.
In contrast, Ina et al. (1987) have shown that IFN-y induces
a rise in Ca2+ and HLA class II antigen expression in HL-60
cells, which again can be efficiently blocked by W7. In
general, the reports on IFN-y signalling agree that this
cytokine can activate PKC and raise [Ca2+]i by increasing
Ca2+ influx and/or by generating Ins 1,4,5-P3. However, the
effect of PKC inhibitors such as H7 or calmodulin inhibitors
such as W7 on IFN-y-induced antigen expression depends on
the applied cell line and antigen under study (Ina et al., 1987;
Griffiths et al., 1990; Klein et al., 1990; Renkonen et al.,
1990; Hansen et al., 1993).
We conclude that IFN-y can induce a rise in [Ca2+], in
CaKi-I cells which is dependent upon Ca2+ influx as well as
release of Ca2+ from intracellular stores, probably as a result
of Ins 1,4,5-P3 generation. This Ca2+-Ins 1,4,5-P3 response
plays only a minor role during IFN-y-induced ICAM-1
antigen expression and further studies are needed to identify
other signal transduction pathways for IFN-y in our
model.
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